(Q48842485)

English

NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.

scientific article published on 22 March 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial. (English)

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

17

object named as

Manfred Dietel

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

18

object named as

Wilko Weichert

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

author name string

Volker Endris

1

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Albrecht Stenzinger

2

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Nicole Pfarr

3

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Roland Penzel

4

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Markus Möbs

5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Dido Lenze

6

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Silvia Darb-Esfahani

7

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Michael Hummel

8

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Sabine-Merkelbach-Bruse

9

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Andreas Jung

10

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Ulrich Lehmann

11

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Hans Kreipe

12

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Thomas Kirchner

13

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Reinhard Büttner

14

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Wolfram Jochum

15

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Gerald Höfler

16

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Peter Schirmacher

19

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

publication date

22 March 2016

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Virchows Archiv

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

468

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

6

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

697-705

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

https://scigraph.springernature.com/pub.10.1007/s00428-016-1919-8

0 references

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Early events in the pathogenesis of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Semiconductor-based sequencing of formalin-fixed, paraffin-embedded colorectal cancer samples

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-1919-8

21 January 2018

Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/27003155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grading ovarian tumors. Evaluation of decision making by different pathologists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27003155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-throughput diagnostic profiling of clinically actionable gene fusions in lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27003155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-016-1919-8

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/27003155

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48842485&oldid=1650664009"